Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-23
1999-11-09
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514280, 514284, 546 41, 546 48, 546 61, C07D22118, A61K 3133
Patent
active
059815418
ABSTRACT:
The present invention provides compounds of formula (I): ##STR1## wherein R.sub.1 -R.sub.7, W, X, Y, and Z have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are are useful as anticancer agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula I, processes for preparing compounds of formula I, and intermediates useful for preparing compounds of formula I.
REFERENCES:
patent: Re26065 (1966-07-01), Marvel et al.
patent: 2915523 (1959-12-01), Moore et al.
patent: 2981731 (1961-04-01), Moore et al.
patent: 2985661 (1961-05-01), Hien et al.
patent: 3267107 (1966-08-01), Sallay et al.
patent: 3272707 (1966-09-01), Tedeschi et al.
patent: 3449330 (1969-06-01), Guglielmetti et al.
patent: 3538097 (1970-11-01), Lowe et al.
patent: 3849561 (1974-11-01), Iwasa et al.
patent: 3884911 (1975-05-01), Shimada et al.
patent: 4761477 (1988-08-01), Ikekawa et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4980344 (1990-12-01), Maroko
patent: 5106863 (1992-04-01), Hajos et al.
patent: 5112532 (1992-05-01), Ninomiya et al.
patent: 5126351 (1992-06-01), Luzzio et al.
patent: 5190753 (1993-03-01), Behrens et al.
patent: 5244903 (1993-09-01), Wall et al.
patent: 5318976 (1994-06-01), Luzzi et al.
patent: 5639759 (1997-06-01), Magolda et al.
patent: 5646283 (1997-07-01), Suzuki et al.
Baezner, C., "Uberfuhrung von o-nitround o,p-dinitro-benzylchlorid in acridinderivate", Berichte der Deutschen Chemischen Gesellschaft, vol. 37, Weinheim, DE, pp. 3077-3083, (1904).
Baezner, C., et al., "Uberfuhrung von o-nitro- und o,p-dinitro-benzylchlorid in acridinderivate", Berichte der Deutschen Chemischn Gessellschaft, vol. 39, pp. 2438-2447, (1906).
Buu-Hoi, N., "The chemistry of carcinogenic nitrogen compounds. Part V. Angular hydroxybenzacridines and hydroxydibenzacridines", Journal of the Chemical Society, Letchworth GB, pp. 2096-2099, (1950).
Buu-Hoi, N., et al., "The chemistry of carcinogenic nitrogen compounds. Part X. The Pfitzinger reaction in the synthesis of 1:2 benzacridines", Journal of the Chemical Society, Letchworth, GB, pp. 279-281, (1952).
Chen, A.Y., et al., "A New Mammalian DNA Topoisomerase I Poison Hoechst 33342: Cytoxicity and Drug Resistance in Human Cell Cultures", Cancer Research, vol. 53, pp. 1332-1337, (Mar. 15, 1993).
Croisy, M., et al., "Synthesis and Carcinogenic Activity of Oxidized Benzacridines: Potential Metabolites of the strong carcinogen 7-Methylbenz[c]acridine and of the inactive isomer 12-methylbenz[a]acridine", J. Med. Chem, 26, pp. 303-306, (1983).
Fujii, N., et al., "Induction of Mammalian DNA Topoisomerase I-mediated DNA Cleavage and DNA Winding by Bulgarein", Journal of Biological Chemistry, vol. 268, pp. 13160-13165, (1993).
Gandhi, K.K., et al., "Regioselective thermal cyclization of 3-substituted arylenaminoimine hydrochlorides, a convenient method for the synthesis of functionalized polycyclic quinoline derivatives", Heterocycles, vol. 41, No. 5, Amsterdam, NL, pp. 911-920, (1995).
Gatto, B., et al. "Identification of Topoisomerase I as the Cytotoxic Target of the Protoberberine Alkaloid Coralyne", Cancer Research, vol. 56, pp. 2795-2800, (1996).
Hoan, N., et al., "Syntheses from o-halogenated anisoles and phenetoles", Chemical Abstracts, Abstr. No. 6571bg, vol. 41, No. 20, Columbus, Ohio, (Oct. 20, 1947).
Janin, Y., et al., "Synthesis and Evaluation of New 6-Amino-Substituted Benzo[c]phenanthridine Derivatives" J. Med. Chem., vol. 36, pp. 3686-3692 (1993).
Kametani, T., et al., "Studies on the synthesis of heterocyclic compounds. DCXXVII. The formation of 2,3,9,10-tetramethoxybenz[c]acridine by treatment of 6,7-dimethoxy-1-(4,5-dimethoxy-2-nitrophen ethyl)-2methylisoquinoline with triethyl phosphite", Chemical and Pharmaceutical Bulletin, vol. 23, No. 9, pp. 2025-2028, (1975).
Kim, J.S., et al., "Substituted 2,5'-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity", J. Med. Chem., vol. 39, 992-998, (1996).
Makhey, D., et al., "Coralyne and Related Compounds as Mammalian Topoisomerase I and Topoisomerase II Poisons", Bioorg. & Med. Chem. Lett., vol. 4, 781-791, (1996).
Makhey, D., et al., "Protoberberine Alkaloids and Related Compounds as Dual Inhibitors of Mammalian Topoisomerase I and II", Med Chem. Res., vol. 5, 1-12, (1994).
Mohanty, M., et al., "New Therapeutic agents of the quinoline series. I. Fused quinolyl compounds", Chemical Abstracts, vol. 69, No. 5, p. 1792, (Jul. 29, 1968).
Stermitz, F.R., et al., "Synthesis and Biological Activity of Some Antitumor Benzophenanthridinum Salts", Journal of Medicinal Chemistry, vol. 18, pp. 708-713, (1975).
Sun, Q., et al., "Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inhibitors", J. Med. Chem, vol. 38, pp. 3638-3644, (1995).
Wang, L., et al., "Inhibition of Topoisomerase I Function by Coralyne and 5,6 -Dihydrocoralyne", Chem. Res. Toxicol., vol. 9, pp. 75-83, (1996).
Wang, L., et al., "Inhibition of Topoisomerase I Function by Nitidine and Fagaronine", Chem. Res. Toxicol., vol. 6, pp. 813-818, (1993).
Yamashita, Y., et al., "Induction of Mammalian DNA Topoisomerase I and II Mediated DNA Cleavage by Saintopin, a New Antitumor Agent from Fungus", Biochemistry, vol. 30, pp. 5838-5845, (1991).
Yamashita, Y., et al., "Induction of Mammalian DNA Topoisomerase I Mediated DNA Cleavage by Antitumor Indolocarbazole Derivatives", Biochemistry, vol. 31, pp. 12069-12075, (1992).
Badia, D., et al., "Silicon-mediated isoquinoline synthesis: preparation and stereochemical characterization of 4-hydroxy-3-phenylisoquinolines", Chemical Abstracts, vol. 117, No. 13, Abstract No. 131034, Tetrahedron; 92, vol. 48 (21), pp. 4419-4430, (Sep. 28, 1992).
Bathini, Y., et al., "Convenient Routes to Substituted Benzimidazoles and Imidazolo[4,5-b]pyridines Using Nitrobenzene as Oxidant", Synthetic Communications, 20(7), 955-963, (1990).
Bradsher, C.K., et al., ".alpha-Acyl-o-tolunitriles as intermediates in the preparation of 3-substituted isoquinolines and 1-amino-2-benzopyrylium derivatives", Chemical Abstracts, vol. 089, No. 21, Abstract No. 179810, 3817-3820, (1978).
Chen, A.Y., et al., "DNA Minor Groove-Binding Ligands: A Different Class of Mammalian DNA Topoisomerase I Inhibitors", Proc. Natl. Acad. Sci., USA., vol. 90, pp. 8131-8135, (Sep. 1993).
Chen, A.Y., et al., "DNA Topoisomerases: Essential Enzymes and Lethal Targets", Annu. Rev. Pharmacol. Toxicol.,, vol. 34, pp. 191-218, (1994).
Cherif, A., et al., "N-(5,5-Diacetoxypent-1-yl)doxorubicin: A New Intensely Potent Doxorubicin Analogue", J. Med. Chem., 35, 3208-3214, (1992).
D'arpa, P., et al., "Topoisomerase-Targeting Antitumor Drugs", Biochimica et Biophysica Acta, 989, 163-177 (1989).
Dominguez, E., et al., "Dehydrogenation reactions of 1-substituted-3-aryltetrahydroisoquin oline derivatives", Chemical Abstracts, vol. 101, No. 11, Abstract No. 090742, 525-528, (1984).
Dorofeenko, G.N., et al., "Synthesis of 3-aryl derivatives of 2-benzopyrylium salts with free.alpha-positions", Chemical Abstracts, vol. 074, No. 15, Abstract No. 076295, 1013-1014, (1971).
Fitzgerald, J.J., et al., "Reaction of benzocyclobutene oxides with nitriles: synthesis of hypecumine and other 3-substituted isoquinolines", Chemical Abstracts, vol. 122, No. 7, Abstract No. 081704, Tetrahedron Lett. ; 94; vol. 35, (49), pp. 9191-4, (Feb. 13, 1995).
Fox, G.J., et al., "para-Bromination of Aromatic Amines: 4-Bromo-N,N-Dimethyl-3-(Trifluoromethyl)Aniline", Org. Syn., 55, 20-23, (1973).
Gallo, R.C., et al., "Studies on the Antitumor Activity, Mechanism of Action, and Cell Cycle Effects of Camptothecin", Journal of the National Cancer Institute, 46, 789-795 (Apr. 1971).
Garcia, A., et al., "A simple direct approach to 1-substituted 3-arylisoquinolines from deoxybenzoins and nitriles", Chemical Abstracts, vol. 110, No. 25, Abstract No. 231407, Tetrahedron; 88; vol. 44(21);, pp. 6681-6686, (Jun. 19, 1989).
Giovanella, B.C., et al., "Complete Growth Inhibition of Human Cancer Xenografts in Nude Mice by Treatment with 20-(S)--Camptothecin", Cancer Research, 51, 3052-3055 (Jun. 1, 1991).
Iwa
LaVoie Edmond J.
Liu Leroy Fong
Makhey Darshan B.
Rao Deepak R.
Raymond Richard L.
Rutgers The State University of New Jersey
LandOfFree
Substituted heterocycles as anti-tumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocycles as anti-tumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocycles as anti-tumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456384